Affinity Asset Advisors's book
2 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Odyssey Therapeutics | Biotechnology | $638.2M | — | — | |
| TRexBio | — | $274.0M | — | — |
Free account
See the whole book
- ·Watchlist + alerts for Affinity Asset Advisors's activity
Create free account
No card required